Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 10885564 | HLA-B*50 | hematopoietic stem cell transplantation | African American | NA | NA | unclassified | |
| in light of the continuing need to reconcile differences between relationships determined by the sequence homologies among alleles and relationships based on the serologic determinants carried by allelic products when determining the level of hla match for hematopoietic stem cell transplantation, it is suggested that b*5002 be recognized individually from other b*50 alleles when reporting hla-b typings for clinical purposes. | |||||||
| 11315397 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| supportive treatment with transfusions, antimicrobial agents, hematopoietic growth factors and conventional chemotherapy has only palliative character.allogeneic transplantationallogeneic hematopoietic stem cell transplantation from hla-matched family or unrelated donors is currently the only potentially curative therapy. | |||||||
| 11334673 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| in addition to lymphocyte phenotyping and functional assays, new tools are now available to monitor specific aspects of the immune response in the follow-up of hematopoietic stem cell transplantation: reconstitution of t-cell diversity (spectratyping or immunoscope), ex vivo thymic function by measuring "t-cell receptor rearrangement excision dna circles" and antigen-specific t-cell responses (hla tetramers). | |||||||
| 11551024 | HLA MISMATCHED (HLA-MISMATCHED) | ganciclovir | NA | foscarnet | NA | unclassified | |
| NA | |||||||
| 11850713 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| both patients underwent hematopoietic stem cell transplantation, one with a compatible unrelated donor cord blood unit and one with an hla-matched sibling donor bone marrow. | |||||||
| 11923695 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | methotrexate | NA | unclassified | |
| thirteen months after hematopoietic stem cell transplantation, 54% of hla-identical sibling marrow recipients and 36% of unrelated marrow recipients with malignant disease had discontinued immunosuppression (p=0.002). | |||||||
| 12040473 | HLA (HLA) | busulfan | NA | cyclophosphamide | NA | unclassified | |
| NA | |||||||
| 12044056 | HLA-CLASS I (HLA CLASS II) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| cytotoxic t lymphocyte precursor frequency analysis in the selection of hla matched unrelated donors for hematopoietic stem cell transplantation: the correlation of ctlp frequency with hla class i genotyping and agvhd development. | |||||||
| 12044056 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the selection of human leukocyte antigen (hla) compatible unrelated donors for hematopoietic stem cell transplantation (hsct) is based on the direct genotyping of hla class i and class ii alleles (hla-a, -b, -c, -drb1, -dqb1 loci). | |||||||
| 12044056 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the selection of human leukocyte antigen (hla) compatible unrelated donors for hematopoietic stem cell transplantation (hsct) is based on the direct genotyping of hla class i and class ii alleles (hla-a, -b, -c, -drb1, -dqb1 loci). | |||||||
Copyright 2024